Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma Opens Production Facility in Spain | Contract Pharma

What are you searching for?

Sign in
Breaking News

MilliporeSigma Opens Production Facility in Spain

Will exclusively manufacture Meglumine excipient

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has opened a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.  
 
The facility has been validated by the FDA and is currently the only location in Europe that manufactures meglumine, an amino sugar derived from glucose. As an excipient, meglumine interacts directly with active pharmaceutical ingredients to increase solubility and therefore must meet the same stringent regulatory and quality requirements as APIs.
 
“Our new facility was optimized around the manufacturing process to achieve greater efficiencies and meets the most stringent quality standards for manufacturing meglumine,” said Andrew Bulpin, head of Process Solutions Strategic Marketing & Innovation, MilliporeSigma. “The result is a high level of confidence in quality and security of supply for our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics